Free Trial

Cullinan Therapeutics (CGEM) SEC Filings & 10K Form

Cullinan Therapeutics logo
$7.89 +0.02 (+0.25%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$7.99 +0.10 (+1.27%)
As of 08:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cullinan Therapeutics SEC Filings

DateFilerForm TypeView
05/08/2025
6:21 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:24 AM
Cullinan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2025
5:56 AM
Cullinan Therapeutics (Filer)
Form DEF 14A
04/25/2025
5:58 AM
Cullinan Therapeutics (Filer)
Form DEFA14A
04/25/2025
6:00 AM
Cullinan Therapeutics (Filer)
Form ARS
02/27/2025
4:00 PM
Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:00 PM
AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:00 PM
Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:03 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:07 AM
Cullinan Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
6:11 AM
Cullinan Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/21/2025
5:00 PM
Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
5:00 PM
Cullinan Therapeutics (Issuer)
Savill Corrine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
5:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
5:00 PM
Cullinan Therapeutics (Issuer)
Fenton Mary Kay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
5:00 PM
Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
5:00 PM
AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
6:00 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
4:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:22 PM
Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2024
5:00 PM
AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:00 PM
Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:00 PM
Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
4:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:24 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G/A
11/12/2024
1:23 PM
Cullinan Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/07/2024
4:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:06 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:18 AM
Cullinan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
10:18 AM
Cullinan Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
11:48 AM
Cullinan Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G
10/16/2024
6:17 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
6:13 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:27 PM
Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
5:00 PM
Cullinan Therapeutics (Issuer)
Thistle Mary (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2024
6:20 AM
Cullinan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:15 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
07/09/2024
4:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
3:19 PM
Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
6:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Ryan David P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Martin Anne-Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Rosenberg Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Webster Stephen W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:00 PM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
5:00 PM
Cullinan Therapeutics (Issuer)
Ebeling Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
12:30 PM
BlackRock Inc. (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G/A
06/04/2024
11:15 PM
Cullinan Therapeutics (Filer)
Form EFFECT
06/03/2024
7:12 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
4:07 PM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CGEM) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners